|
Volumn 47, Issue 8, 2006, Pages 777-780
|
Bortezomib-induced tumor lysis syndrome with a remarkable elevation of LDH in a case of relapsed and therapy-resistant multiple myeloma
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENCE JONES PROTEIN;
BIOLOGICAL MARKER;
BORONIC ACID DERIVATIVE;
BORTEZOMIB;
DEXAMETHASONE;
LACTATE DEHYDROGENASE;
PYRAZINE DERIVATIVE;
ARTICLE;
BLOOD;
CASE REPORT;
DRUG COMBINATION;
FEMALE;
HUMAN;
MIDDLE AGED;
MULTIPLE MYELOMA;
RECURRENT DISEASE;
TREATMENT OUTCOME;
TUMOR LYSIS SYNDROME;
URINE;
ANTINEOPLASTIC AGENTS;
BENCE JONES PROTEIN;
BIOLOGICAL MARKERS;
BORONIC ACIDS;
DEXAMETHASONE;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
L-LACTATE DEHYDROGENASE;
MIDDLE AGED;
MULTIPLE MYELOMA;
PYRAZINES;
RECURRENCE;
TREATMENT OUTCOME;
TUMOR LYSIS SYNDROME;
|
EID: 39049186710
PISSN: 04851439
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|